EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Effect of mitochondrial oxidative stress on regulatory T cell manufacturing for clinical application in transplantation: Results from a pilot study

Roberto Gedaly, Gabriel Orozco, Lillie J Lewis, Deepa Valvi, Fanny Chapelin, Aman Khurana, Giovanna E Hidalgo, Aaron Shmookler, Aashutosh Tripathi, Cuiping Zhang, Joseph B Zwischenberger, Francesc Marti

American Journal of Transplantation · 2025

DOI: 10.1016/j.ajt.2024.10.024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Transplantation, 2025. Verfasst von Roberto Gedaly und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery - Transplant Division, College of Medicine, University of Kentucky, Lexington, Kentucky, USA; Lucille Parker Markey Cancer Cent…. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Oxidative Stress, Mitochondria, Kidney Transplantation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIBIB NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The manufacturing process of regulatory T (Treg) cells for clinical application begins with the positive selection of CD25+ cells using superparamagnetic iron oxide nanoparticle (SPION)-conjugated anti-CD25 antibodies (spCD25) and immunomagnetic cell separation technology. Our findings revealed that the interaction of spCD25 with its cell target induced the internalization of the complex spCD25-interleukin-2 receptor. Accumulation of intracellular spCD25 triggered oxidative stress, causing delayed Treg expansion and temporary reduction in suppressor activity. This activation delay hindered the efficient generation of clinically competent cells. During this early phase, Treg cells exhibited elevated mitochondrial superoxide and lipid peroxidation levels, with a concomitant decrease in mitochondrial respiration rates. The results uncovered the increased mitochondrial unfolded protein response. This protective, redox-sensitive activity is inherent in Tregs when contrasted with homologous, spCD25-treated, conventional T cells. Although the temporary effects of spCD25 on clinically competent cells did not impede their use in a safety/feasibility pilot study with kidney transplant recipients, it is reasonable to anticipate a potential reduction in their therapeutic efficacy. The mechanistic understanding of the adverse effects triggered by spCD25 is crucial for improving the manufacturing process of clinically competent Treg cells, a pivotal step in the successful implementation of immune cell therapy in transplantation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

T-Lymphocytes, RegulatoryOxidative StressMitochondriaKidney TransplantationPilot ProjectsHumansInterleukin-2 Receptor alpha SubunitMale

Stichwörter der Autor:innen

cellular therapyoxidative stressredox stateregulatory T cellstolerance inductiontransplantation

Substanzen

Interleukin-2 Receptor alpha Subunit

Autor:innen und Institutionen

  • Department of Surgery - Transplant Division, College of Medicine, University of Kentucky, Lexington, Kentucky, USA; Lucille Parker Markey Cancer Center, University of Kentucky, College of Medicine, Lexington, Kentucky,…
  • Department of Surgery - Transplant Division, College of Medicine, University of Kentucky, Lexington, Kentucky, USA. Electronic address: orozcog@ohsu.edu.
  • Department of Surgery - Transplant Division, College of Medicine, University of Kentucky, Lexington, Kentucky, USA. Electronic address: lillie.lewis@uky.edu.
  • Department of Surgery - Transplant Division, College of Medicine, University of Kentucky, Lexington, Kentucky, USA. Electronic address: deepa.valvi@uky.edu.
  • Lucille Parker Markey Cancer Center, University of Kentucky, College of Medicine, Lexington, Kentucky, USA; Alliance Research Initiative (TILT Alliance), University of Kentucky College of Medicine, Lexington, Kentucky,…
  • Pathology and Laboratory Medicine, University of Kentucky, College of Medicine, Lexington, Kentucky, USA. Electronic address: giovanna.hidalgo@uky.edu.

Förderung

  • NCI NIH HHS
  • NIBIB NIH HHS
  • NCATS NIH HHS
  • National Cancer Institute
  • National Institute of Biomedical Imaging and Bioengineering
  • National Center for Advancing Translational Sciences
  • National Institutes of Health
  • Office of the Vice President for Research and Partnerships

Zitieren

APA

Gedaly, R., Orozco, G., Lewis, L. J., Valvi, D., Chapelin, F., Khurana, A., Hidalgo, G. E., Shmookler, A., Tripathi, A., Zhang, C., Zwischenberger, J. B., & Marti, F. (2025). Effect of mitochondrial oxidative stress on regulatory T cell manufacturing for clinical application in transplantation: Results from a pilot study. American Journal of Transplantation. https://doi.org/10.1016/j.ajt.2024.10.024

Vancouver

Gedaly R, Orozco G, Lewis LJ, Valvi D, Chapelin F, Khurana A, et al. Effect of mitochondrial oxidative stress on regulatory T cell manufacturing for clinical application in transplantation: Results from a pilot study. American Journal of Transplantation. 2025. doi:10.1016/j.ajt.2024.10.024

BibTeX
@article{Gedaly2025,
  author = {Gedaly, Roberto and Orozco, Gabriel and Lewis, Lillie J and Valvi, Deepa and Chapelin, Fanny and Khurana, Aman and Hidalgo, Giovanna E and Shmookler, Aaron and Tripathi, Aashutosh and Zhang, Cuiping and Zwischenberger, Joseph B and Marti, Francesc},
  title = {Effect of mitochondrial oxidative stress on regulatory T cell manufacturing for clinical application in transplantation: Results from a pilot study},
  journal = {American Journal of Transplantation},
  year = {2025},
  doi = {10.1016/j.ajt.2024.10.024}
}
Kostenlos starten →